Future of customer engagement in Pharma

Beyond tech: pharma’s people-centric customer engagement

Group of people clapping in courtyard
  • Industry
  • 10 minute read
  • 01/07/25
Elsa Shaughnessy

Elsa Shaughnessy

Director, People and Organisation, PwC Switzerland

Hester  Muhring

Hester Muhring

Manager People & Organisation, PwC Switzerland

Emma Peabody

Emma Peabody

Manager, People and Organisation, PwC Switzerland

Strong customer relationships between pharmaceutical companies and medical institutions are fundamental for high-performing healthcare ecosystems that deliver optimal outcomes for patients and healthcare professionals (HCPs). As healthcare ecosystems across the globe contend with rising costs and growing demand, the ability to deliver personalised, seamless customer experiences is becoming even more critical. With rising expectations from HCPs and mounting pressure to improve outcomes, customer engagement is no longer a support function – it has become a strategic priority.

Pharmaceutical companies are racing to modernise outdated customer engagement (CE) platforms with the ambition of delivering more connected, personalised customer experiences. In Switzerland, where many global pharma giants are headquartered, this shift is especially visible. However, despite millions being invested in next-generation systems, many customer engagement initiatives underperform. The reason? Too much focus on perfecting and customising the technology and not enough on people adopting it and using it effectively.

As is now widely recognised, the majority of digital transformations fail to deliver the intended benefits, largely because of poor adoption and resistance to change. In the pharma industry – where commercial and medical teams often work in silos, data governance is complex and relationships are everything – challenges around proper user adoption are magnified.

This article explores:

  • Why customer engagement transformation is uniquely difficult in pharma
  • The people-related pitfalls that commonly derail progress
  • What Swiss and global pharma leaders can do differently to ensure success.

When done right, customer engagement platforms can be a powerful engine for collaboration and insight-sharing. But unlocking that value requires more than new technology. It demands a human-centred approach to change

  • Lack of a compelling case for CE: Employees lack a clear and urgent understanding of why transforming customer engagement is critical now for better patient outcomes and sustained competitiveness.
  • Leadership misalignment: Leaders often talk about transformation but fail to demonstrate the customer-centric mindset and collaborative behaviours needed to make it real.
  • Unchanged processes, structures and incentives: Without aligned KPIs, systems and workflows, it becomes difficult for employees to shift towards more integrated and insight-driven engagement.
  • Lack of personal relevance for employees: When employees don’t see how the transformation benefits their role or purpose, it remains an abstract initiative rather than a motivating force.

Why customer engagement initiatives fall short

Barriers to extracting the full value from customer engagement platforms are rarely technological. They usually stem from leadership misalignment, resistance to change and a fragmented approach to adoption. Too often, a CE platform implementation is treated as a tool rollout rather than a behavioural and even cultural shift, with system training prioritised over real integration in day-to-day operations. True customer relationship management requires more than software; it demands a mindset shift that breaks down barriers and ensures insights flow seamlessly throughout the organisation

We see the following root causes behind the underperformance of customer engagement platforms:

1. Leadership misalignment

When leadership isn’t aligned on the strategic goals of customer engagement, adoption becomes a box-ticking exercise rather than a business enabler. Without a shared vision and visible sponsorship, employees are less likely to understand how CE supports the organisation’s broader purpose and invest the necessary effort to adopt the system.

2. Change without enablement

Many programmes overinvest in training and underinvest in change support. Users are shown how to click buttons but not how the system will help them be more effective in their roles. Without real-life use cases and embedded workflows, users revert to old habits.

3. Cultural resistance

Fear of losing control over customer relationships is common, particularly among medical and commercial teams. When information is seen as power, efforts to centralise or standardise system usage can trigger protectionist behaviours and undermine collaboration.

4. Siloed execution

Ways of working around customer engagement often differ across countries and business units, for example owing to local regulations. In Switzerland, where global, regional and local teams must collaborate, these inconsistencies can be particularly challenging. Misaligned processes result in fragmented information sharing and inconsistent customer experiences.

From technology rollout to behavioural change

To overcome these challenges, pharma companies must treat customer engagement transformations as a people initiative, not just a tech project. When supporting our clients with these engagements, we take the following aspects into account:

Connect customer engagement to strategic goals

A clear case for change or strategic narrative must link customer engagement directly to the broader organisational strategy. The message should be simple and relevant for all employees. It should explain what is changing and why it matters – both for the organisation’s mission and for each individual’s role. Anchoring the message in how stronger customer relationships enable better healthcare systems and improved patient outcomes will make it relatable across the business.

Activate leaders as champions

The CE transformation’s success depends on visible, active leadership. Leaders must walk the talk by using the system themselves, reinforcing key messages in their own words and role-modelling collaborative behaviours. Approval isn’t enough; sustained sponsorship is critical.

Tailor the experience by role

Field reps, marketing leads and market access teams all interact with customers differently. One-size-fits-all change approaches rarely work. Successful adoption requires role-specific messaging and support. Focus on delivering personalised value: What insights will make their work easier, smarter and more impactful?

Embed into daily workflows

Adoption only sticks when customer engagement platforms are embedded in the way people already work. Deployment teams must deeply understand frontline realities, balancing standardisation with necessary local adaptations. Prioritise “just-in-time” support, quick reference guides and real-time help desks, ensuring employees are supported exactly when they need it.

Address mindsets, not just skills

Changing behaviour means bringing the underlying beliefs and fears to the surface, especially around customer data sharing and transparency. Foster a culture of openness and information sharing by making it safe and desirable to collaborate. Use practical examples, workshops and peer discussions to bring dilemmas to the surface (for example balancing relationship ownership with transparency) and collectively define what “good” looks like. Recognise that customer engagement success in pharma often challenges deeply ingrained habits.

Track adoption, not just usage

Go-live is the starting line, not the finish. Measure leading indicators like frequency of use, quality of input and collaboration across teams – not just login rates. Define clear metrics linked to business outcomes and use them to continuously refine and evolve both the platform and the ways of working.

Create feedback loops

Empower users to shape the system. Create agile update cycles where enhancements to both the technology and ways of working are prioritised based on real user feedback. In pharma, where market dynamics and HCP expectations evolve rapidly, maintaining flexibility and responsiveness is critical to keeping the customer engagement system valuable and relevant over time.

Why this matters now

As healthcare ecosystems become more interconnected, pharma companies are under pressure to prove value – not just through products, but through partnerships. Strong customer relationships, powered by shared insights and aligned teams, are central to that mission.

In Switzerland and beyond, CE platforms offer a path to deeper engagement and more impactful interactions with HCPs. But without embedding new mindsets, workflows and ways of working, even the best technology will still fall short.

Final thought: tech alone won’t get you there

The future of customer engagement in pharma isn’t about having the smartest system. It’s about creating the conditions where people use it to work smarter – together.

That’s why change management isn’t an add-on. It’s the backbone of any customer engagement initiative that aims to shift behaviour, break down silos and deliver on the promise of customer centricity.

Invest in the people side of change and you’ll unlock the real power of your CE technology.

We’re there to give pharma companies the confidence to take the bold steps necessary to get the most out of their customer engagement efforts. Please reach out if you’d like to discuss your approach in more depth.

Contact us
Elsa Shaughnessy

Elsa Shaughnessy

Director, People and Organisation, PwC Switzerland

Hester  Muhring

Hester Muhring

Manager People & Organisation, PwC Switzerland

Emma Peabody

Emma Peabody

Manager, People and Organisation, PwC Switzerland